To gain insights into the function of SUVH2/SUVH9, we solved the crystal structure of an N-terminally-truncated SUVH9 construct (residues 134 -- 650), which contains all the known functional domains (the SRA, pre-SET, and SET domains) ([Fig. 1a](#F1){ref-type="fig"}, [Extended Data 1a and Supplementary Table 1](#SD1){ref-type="supplementary-material"}). The structure of SUVH9 is composed of three segments: a two-helix bundle towards the N-terminus (residues 138 - 194), the SRA domain (residues 195 - 379), and the pre-SET/SET domains (residues 380 - 637). There are extensive inter-domain interactions that can stabilize the overall architecture of the protein ([Fig 1a](#F1){ref-type="fig"} and [Extended Data Fig. 1b-g](#F5){ref-type="fig"}).

The SRA domain of SUVH9 resembles those of UHRF1 and SUVH5^[@R10]-[@R13]^ ([Fig. 1b](#F1){ref-type="fig"}). Based on the SUVH5 SRA-mCHH DNA complex structure^[@R13]^, we modeled a mCHH DNA into SUVH9 ([Extended Data Fig. 2a](#F6){ref-type="fig"}). The DNA could be positioned in the nucleic acid-binding cleft of the SRA domain without significant steric clashes and the proposed flipped-out 5mC base readily inserts into the binding pocket of the SRA domain.

Although SUVH9 contains histone methyltransferase pre-SET and SET domains similar to Dim5, G9a, and GLP^[@R14]-[@R16]^ ([Extended Data Fig. 2b](#F6){ref-type="fig"}), it exhibits neither detectable histone methyltransferase activity nor binding capacity for the SAM cofactor *in vitro*^[@R8]^. SUVH9 and SUVH2 lack post-SET domains that are normally critical for cofactor and peptide substrate binding, as well as catalysis ([Extended Data Fig. 3](#F7){ref-type="fig"}). Compared with the structure of human H3K9 methyltransferase GLP ([Fig. 1c, d](#F1){ref-type="fig"}), the putative S-adenosylhomocysteine (SAH)-binding pocket and peptide binding channel of SUVH9 are very open and incompletely formed ([Fig. 1e, f](#F1){ref-type="fig"}) and cannot stably retain either a bound SAH molecule or the peptide substrate, especially in the absence of the stabilizing role of the post-SET domain. In summary, the SUVH9 structure is consistent with the demonstrated ability of SUVH9 to bind to methylated DNA, and supports the view that SUVH9 (and SUVH2) proteins encode inactive methyltransferase homologs.

We sought to further characterize the role of SUVH2 and SUVH9 in the RdDM pathway by determining their effect on siRNAs genome-wide. Most siRNAs are eliminated in Pol IV (*nrpd1*) mutants, while only some siRNAs are reduced in Pol V (*nrpe1*) mutants^[@R17]^ ([Fig 2a](#F2){ref-type="fig"}). We found that the *suvh2 suvh9* double mutant reduced siRNA abundance at siRNAs clusters that were dependent on both Pol IV and Pol V, but not at Pol V-independent clusters ([Fig. 2a, b](#F2){ref-type="fig"}). Thus, the *suvh2 suvh9* double mutant siRNA phenotype closely resembles that of a Pol V mutant. We next sought to determine whether SUVH2/9 might be involved in the production of non-coding transcripts by Pol V. At two characterized sites (IGN22 and P6)^[@R18],[@R19]^ we found that *suvh2 suvh9* reduced Pol V transcripts to the same extent as *nrpe1* ([Fig. 2c](#F2){ref-type="fig"}). Similar results were observed at the *AtSN1* locus in *suvh2 suvh9*^[@R9]^. To test if SUVH2/9 are required for Pol V chromatin occupancy, we utilized chromatin immunoprecipitation (ChIP) of a Flag-tagged NRPE1 (the largest subunit of Pol V). We observed only background levels of Pol V binding at IGN5 and IGN22 in *suvh2 suvh9* compared to a six-fold enrichment in wild type (WT; [Fig. 2d](#F2){ref-type="fig"}). We further analyzed our ChIPs by next generation sequencing (ChIP-Seq) and found that binding of Pol V at all previously identified sites^[@R18]^ was significantly decreased or eliminated in *suvh2 suvh9* ([Fig. 2e, f](#F2){ref-type="fig"}).

To determine the effect of SUVH2/9 on DNA methylation at defined Pol V binding sites, we utilized whole-genome bisulfite sequencing (BS-Seq). As in *nrpe1*, CHH methylation at Pol V binding sites was eliminated in *suvh2 suvh9* ([Fig. 3a](#F3){ref-type="fig"}). We also analyzed BS-Seq of the single mutants *suvh2* and *suvh9* to determine if SUVH2/SUVH9 act redundantly at all sites or have non-overlapping sites where they function. We found that *suvh2* had a stronger effect than *suvh9* at Pol V sites as well as at differentially methylated regions (DMRs) defined in either *suvh2* or *suvh9* single mutants, or in the *suvh2 suvh9* double mutant ([Extended Data Fig. 4a-c](#F8){ref-type="fig"}). These results indicate that SUVH2 and SUVH9 act redundantly throughout the genome to control RdDM.

Our results suggest that a reinforcing loop exists between DNA methylation and Pol V binding via SUVH2/9. To further test this model we utilized a mutation in the maintenance methyltransferase MET1 that eliminates CG methylation genome-wide and also reduces CHG and CHH methylation^[@R20]-[@R22]^ ([Fig. 3b](#F3){ref-type="fig"}). Using endogenous antibodies to NRPE1, ChIP-seq revealed that Pol V occupancy was virtually eliminated in *met1* at sites normally occupied by Pol V ([Fig. 3c](#F3){ref-type="fig"} and [Extended Data Figs. 5](#F9){ref-type="fig"}-[7](#F11){ref-type="fig"}). In contrast, at sites previously identified as gaining methylation in *met1*^[@R21]^, we observed an increase in Pol V binding ([Fig. 3d, e](#F3){ref-type="fig"}, and [Extended Data Figs. 8](#F12){ref-type="fig"}, [9](#F13){ref-type="fig"}). Furthermore, point mutations in the SRA domains of SUVH2 and SUVH9 were shown to cause a loss of RdDM^[@R8]^. Together, these results suggest that SUVH2/SUVH9 binding to methylated DNA recruits Pol V, thus providing a link between preexisting DNA methylation and the recruitment of further methylation by RdDM.

To test directly whether SUVH2/SUVH9 may be sufficient to recruit Pol V, we utilized a zinc finger (ZF) to tether SUVH2 to an unmethylated epiallele of *FWA*, *fwa-4. FWA* is normally silenced due to DNA methylation of tandem repeats in its promoter^[@R23]^. *FWA* epialleles have lost this methylation, leading to ectopic expression of *FWA* and a heritable late flowering phenotype^[@R23],[@R24]^. Surprisingly, siRNAs are still observed in *fwa* epialleles but are unable to direct DNA methylation^[@R25]^. We hypothesized that Pol V transcripts may be missing in *fwa* epialleles and that recruitment of Pol V by SUVH2 might therefore stimulate *FWA* methylation and silencing. To test this we transformed a ZF-SUVH2 fusion protein construct into the *fwa-4* epiallele ([Extended Data Fig. 10a](#F14){ref-type="fig"}). As negative controls, we also transformed an HA-tagged SUVH2 line without the ZF (HA-SUVH2) as well as a construct in which the ZF was fused to KRYPTONITE (KYP/SUVH4) (a SUVH protein not required for RdDM).

Approximately 75% of the *fwa-4* plants transformed with the ZF-SUVH2 (T1 generation) flowered early as compared to the parental *fwa-4* line, suggesting silencing of *FWA* ([Fig. 4a](#F4){ref-type="fig"}). The *fwa-4* line transformed with HA-SUVH2 or ZF-KYP flowered at the same time as the *fwa-4* parent showing that the effect was specific to the ZF-SUVH2 fusion. Flowering time was measured in the T2 generation confirming these observations ([Fig. 4b](#F4){ref-type="fig"}). The presence of the control ZF-KYP at *FWA* was shown by ChIP ([Extended Data Fig. 10b](#F14){ref-type="fig"}); however we were unable to detect the ZF-SUVH2 most likely due to its instability or low abundance.

We next utilized bisulfite sequencing to determine if *FWA* gene silencing was associated with DNA methylation. In wild type, DNA methylation was detected over a large region, while in both *fwa-4* and transformants with ZF-KYP or HA-SUVH2, this region was devoid of DNA methylation (see ZF-KYP; [Fig. 4c](#F4){ref-type="fig"}). In three independent ZF-SUVH2 T1 lines, DNA methylation was observed immediately around the Zn finger binding sites in all cytosine sequence contexts ([Extended Data Fig. 10c](#F14){ref-type="fig"}). We analyzed one of the lines (ZF-SUVH2-2) in the T2 and T3 generations using BS-seq and found that methylation extended approximately 150 base pairs in either direction from the binding sites and did not expand significantly between generations ([Fig. 4c](#F4){ref-type="fig"}). *FWA* methylation and gene silencing were maintained in T2 plants that had segregated away the ZF-SUVH2 transgene ([Extended Data Fig. 10d](#F14){ref-type="fig"}), indicating that targeting by SUVH2 is capable of inducing DNA methylation and gene silencing that can be maintained in the absence of the initial trigger.

To determine whether Pol V was present at *FWA*, we utilized NRPE1 ChIP. As expected, we found enrichment of Pol V at two known Pol V sites, IGN5 and IGN22, in the wild-type and *fwa-4* lines, but not in *nrpe1* mutant plants ([Fig. 4d](#F4){ref-type="fig"}). At *FWA*, we found enrichment of Pol V in the wild type at both the promoter and transcript regions, but not in *nrpe1* or *fwa-4* ([Fig. 4d](#F4){ref-type="fig"}). However in the ZF-SUVH2-transformed *fwa-4* plants we could now see enrichment of Pol V at *FWA* ([Fig. 4d](#F4){ref-type="fig"}), indicating that SUVH2 is sufficient to recruit Pol V.

To look for a direct interaction between SUVH2/9 and Pol V, we queried several IP-mass spectrometric datasets from purifications of NRPE1-Flag, but failed to find any SUVH2/9 peptides. However, we did identify SUVH2 peptides in two independent mass spectrometric datasets from DRD1 purifications^[@R6]^ ([Supplementary Table 2](#SD1){ref-type="supplementary-material"}). DRD1 is a component of the DDR complex (also containing DMS3 and RDM1) which interacts with Pol V^[@R6]^ and is required for Pol V occupancy throughout the genome^[@R18]^. The number of SUVH2 peptides observed was lower than those from the DMS3 and RDM1 proteins and also lower than the level of peptides of most Pol V complex components, suggesting that the interaction between SUVH2 and DRD1 is weaker or more transient than the interaction between the DDR components or between DDR and Pol V. To confirm the interaction, we performed co-immunoprecipitation experiments with HA-tagged SUVH2 and Flag-tagged DRD1 in transgenic Arabidopsis plants and were able to detect HA-SUVH2 in a Flag-DRD1 pull-down ([Fig. 4e](#F4){ref-type="fig"}). We were also able to detect Flag-DRD1 in a pull-down using HA-SUVH2 expressed in leaves of *Nicotiana benthamiana* and purified on HA magnetic beads (Extended Data 10e). These results confirm the IP-mass spectrometry observations and are consistent with a model in which SUVH2 acts indirectly via a transient interaction with DRD1 to recruit Pol V.

Because RdDM is triggered at genomic locations that synthesize both Pol IV-dependent siRNAs and Pol V-dependent non-coding transcripts, it is critical to understand the mechanisms that direct Pol IV and Pol V to chromatin. Furthermore, since RdDM functions to silence transposons that do not necessarily share consensus DNA sequences, a strong prediction is that Pol IV and Pol V will utilize epigenetic information in their targeting. We propose that SUVH2/9 serve as critical components of this targeting system by recruiting Pol V to DNA methylation. We recently showed that recruitment of Pol IV involves SHH1, a protein that binds to histone H3 lysine 9 methylation, a silencing mark also found at RdDM sites^[@R26]-[@R28]^. Therefore, the dual marks of DNA methylation and histone H3 lysine 9 methylation appear to act in self-reinforcing loop mechanisms to maintain Pol V and Pol IV at sites of RdDM. These mechanistic findings also suggest a means for selectively targeting DNA methylation by directing both siRNAs and Pol V to overlapping regions of genome, paving the way to chromatin engineering in crop plants.

Similar to other components of RdDM, SUVH2/SUVH9 are required for the establishment of *de novo* DNA methylation during transformation of an unmethylated *FWA* gene into *Arabidopsis*^[@R8]^. An interesting question is how an originally unmethylated DNA is first recognized as an RdDM target if SUVH2/9 DNA methylation-mediated Pol V recruitment cannot initially occur. One possibility is that shortly after the transgene is integrated into the genome, a permissive chromatin environment may allow RNA Pol V (or another polymerase) to produce surveillance transcripts that might serve to initiate RdDM through siRNA-mediated recruitment of DRM2. After this initial round of DNA methylation, SUVH2/9 could then bind methylated DNA and recruit Pol V for subsequent rounds of transcription. In this way, a self-reinforcing loop would be established where preexisting DNA methylation is required for the maintenance of RNA-directed DNA methylation.

Online Methods {#S2}
==============

Biological materials {#S3}
--------------------

All plants used in this study were of the *Arabidopsis thaliana* Columbia-0 (Col-0) accession, with WT referring to the parental strain. The *nrpe1-12* T-DNA (SALK_033852), *met1-3*, and the *suvh2 suvh9* double mutant lines were described previously^[@R18],[@R29],[@R8]^. NRPE1-FLAG transgenic plants^[@R30]^ were crossed to the *suvh2 suvh9* double mutant and homozygous F2 plants were identified. The *fwa-4* epiallele was isolated from a *met1-3* segregating population.

Experimental procedures in Arabidopsis {#S4}
--------------------------------------

ChIPs were performed as described previously^[@R31]^ except that ground tissue was cross-linked with formaldehyde in the following buffer: 10 mM HEPES pH 8.0, 1 M Sucrose, 5 mM KCl, 5 mM MgCl~2~, 5 mM EDTA, and 0.6% Triton X-100. Libraries for NRPE1 ChIP-Seq were generated using the Ovation Ultralow DR Multiplex System (NuGen). Bisulfite sequencing followed by PCR amplification and cloning of *FWA* fragments was done using EZ DNA Methylation-Gold kit (Zymo Research) as described previously^[@R8]^. BS-Seq libraries were generated as previously reported^[@R26]^ and all libraries were sequenced using the HiSeq 2000 platform following manufacturer instructions (Illumina) at a length of 50 bp.

Co-immunoprecipitation experiments {#S5}
----------------------------------

*Nicotiana benthamiana* was infiltrated with pLJ322 (ZF-HA-SUVH2 in JP746^[@R8]^) and leaves were collected after 3 days. Leaves that were not infiltrated were used as a negative control. *3* g of tissue was ground in liquid N~2~ and resuspended in 12 ml of IP buffer (50 mM Tris pH 8.0, 150 mM NaCl, 5 mM MgCl~2~, 10% glycerol, and 0.1% NP40) with 1 μg/ml pepstatin, 1 mM PMSF, and 1X complete protease inhibitor tab-EDTA (Roche). The extracts were filtered through miracloth and centrifuged for 5 min at 3,000*g*. 200 μl HA-magnetic beads (MRL) were added and rotated at 4°C for 45 min. After 3 washes with IP buffer, these were then incubated with DRD1-Flag Arabidopsis flower extracts made in the same fashion. Incubation continued for 45 min rotating at 4°C. The beads were washed 3 times with IP buffer and boiled in 60 μl SDS dyes. Western blots were probed with either anti-Flag-HRP or anti-HA-HRP antibodies. The co-IP experiment in Arabidopsis was performed starting with 2 g of flowers from plants expressing HA-SUVH2, Flag-DRD1 or T2 plants expressing both HA-SUVH2 and Flag-DRD1. Extracts were made as described above and 100 ul of Flag-magnetic beads (Sigma) were added and incubated with rotation at 4°C for 45 min. Washes and western blots were performed as described above.

Data analysis {#S6}
-------------

Bisulfite-Seq (BS-Seq), small RNA-Seq, and ChIP-Seq reads were aligned to the TAIR10 version of the *Arabidopsis thaliana* reference genome using BS-seeker for BS-Seq data and Bowtie for the small RNA-Seq and ChIP-Seq data. For BS-Seq up to 2 mismatches were allowed, whereas for endogenous NRPE1 ChIP and small RNA sequencing only 1 mismatch was allowed. For NRPE1-Flag ChIP, only perfect matches were used and the TAIR8 version of the genome was used to match an earlier report^[@R18]^. For BS-seq and ChIP-seq, only uniquely mapping reads were used. For small RNA-seq, reads were normalized as previously described^[@R26]^.

The small RNA clusters used in [Fig. 2a and 2b](#F2){ref-type="fig"} were previously defined as "*pol-iv* only" and "*shh1/drm2/pol-v*" dependent clusters, respectively^[@R26]^.

For NRPE1-Flag ChIP, enrichment over NRPE1 sites^[@R18]^ was normalized to Flag ChIP in Columbia (negative control). For ChIP-Seq using the endogenous Pol V antibody, the read density over Pol V peaks was calculated using the reads per kilobase per million reads (RPKM) metric. For the purposes of [Figs. 2e, f](#F2){ref-type="fig"}, [3a, b, and d](#F3){ref-type="fig"}, and [Extended Data Fig. 4b](#F8){ref-type="fig"}, Pol V sites were used as previously defined^[@R18]^. For the purposes of [Fig. 3e](#F3){ref-type="fig"}, Pol V enrichment was compared to *met1* hypermethylated CHH sites^[@R21]^. To ensure these sites were comparable in genomic character, all sites were expanded to be 1,000 bp in length, defined by extending the borders of sites +/−500 bp from the previously defined midpoint. For *met1* hypermethylated CHH sites, we applied a size filter to the previously described sites^[@R21]^ so that we retained only sites larger than 100 bp. This was in an effort to filter out sites of spurious CHH methylation and retain *bona fide* hypermethylation sites in the *met1* mutant.

DMR definitions {#S7}
---------------

Deferentially methylated regions (DMRs) were defined for the *suvh2 suvh9*, *suvh2*, and *suvh9* libraries by comparing methylation profiles to a suite of wild-type libraries as previously described^[@R32]^.

Zn finger constructs {#S8}
--------------------

The *FWA* promoter region contains two small direct repeats followed by two larger repeats^[@R33]^. We designed a peptide containing six ZFs that would recognize a sequence found in each of two small repeats (CGGAAAGATGTATGGGCT)^[@R34],[@R35]^. The peptide containing 6 Zn fingers was designed as described previously^[@R33],[@R34]^ and cloned into pUC57 with Xho I sites at both ends (Genewiz). This Xho I fragment was excised and inserted into the unique Xho I site located upstream of the HA tag in our pENTR-SUVH2 construct^[@R8]^, which encodes an HA-tagged SUVH2 driven by the endogenous SUVH2 promoter. This ZF-SUVH2 fragment was then recombined into JP726^[@R8]^ and introduced into *fwa-4* using agrobacterium-mediated transformation. The ZF was also fused to the N terminus of the KRYPTONITE H3K9 methyltransferase and transformed into *fwa-4*.

Protein preparation {#S9}
-------------------

The N-terminal truncated SUVH9 (residues 134 - 650) was cloned into a pFastBacHT B vector (Invitrogen), which fuses a hexa-histidine tag followed by a TEV cleavage site to the N-terminus of the target gene. The plasmid was transformed into *E. coli* strain DH10Bac (Invitrogen) to generate the bacmid. Baculovirus was generated by transfecting Sf9 cells with the bacmid following standard Bac-to-Bac protocol (Invitrogen). The harvested virus was subsequently used to infect the suspended Hi5 cell for recombinant protein expression. The recombinant protein was first purified using nickel affinity chromatography column (GE Healthcare). The hexa-histidine tag was cleaved by TEV protease. The target protein was further purified using a Q sepharose column and a Superdex G200 gel filtration column (GE Healthcare). The purified protein was concentrated to 15 mg/ml and stored at −80°C.

Crystallization {#S10}
---------------

Before crystal screening, the SUVH9 protein was mixed with the putative cofactor S-adenosyl-L-homocysteine (SAH) in a molar ratio of 1:3 or with SAH and a histone H3(1-15) peptide in a molar ratio of 1:3:3 at 4°C for 2 hours. Crystallization of the SUVH9 was carried out at 20°C using the hanging drop vapor diffusion method by mixing 1 μl protein sample at a concentration of 11.5 mg/ml and 1 μl reservoir solution and equilibrating against 500 μl reservoir solution. SUVH9 was crystallized in the condition of 0.2 M potassium thiocyanate, 0.1 M Bis-Tris propane, pH 7.5, and 20% PEG 3350 in free form, as well as in the presence of SAH or in the presence of SAH and H3(1-15) peptide. Square-shaped crystals appeared in 2 weeks. All the crystals were dipped into reservoir solution supplemented with 15% glycerol and flash cooled into liquid nitrogen for diffraction data collection. The diffraction data were collected at beamline X29A, National Synchrotron Light Source (NSLS) at Brookhaven National Laboratory (BNL), New York at the zinc peak wavelength. The data were indexed, integrated, and further scaled with the program HKL2000^[@R36]^. The statistics of the diffraction data are summarized in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}.

For investigating the molecular mechanism for recognition of mCHH containing DNA by SUVH9, we have extensively screened SUVH9 in complex with DNAs as a function of length and termini. We used DNA lengths from 8 bp to 20 bp, with a blunt end or with one or two nucleotides overhanging at either 5' ends or 3' ends, all of which containing a central mCHH site. Unfortunately, we were not able to get any hits on the SUVH9-DNA complex. The methylated and unmethylated oligos were purchased from Keck Oligonucleotide Synthesis Facility at Yale University and Life Technologies, respectively.

Structure Determination and Refinement {#S11}
--------------------------------------

The structure of SUVH9 in the free state was solved using single-wavelength anomalous dispersion method implemented in the program Phenix^[@R37]^. The model building was carried out using the program Coot^[@R38]^ and structural refinement using the program Phenix^[@R37]^. Throughout the refinement, a free *R* factor was calculated using 5% random chosen reflections. The stereochemistry of the structural model was analyzed using the program Procheck^[@R39]^. The statistics of the refinement and structure models are shown in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}. Although we have also collected data for the crystals of SUVH9 in the presence of SAH and in the presence of SAH and H3(1-15) peptide, we observed no electron density for either the SAH moiety or the peptide. Our data are indicative that crystals of SUVH9 in presence of SAH and in the presence of SAH and H3(1-15) peptide are indeed the crystal of free form SUVH9. All the molecular graphics were generated with the program Pymol (DeLano Scientific LLC). The sequence alignment was conducted using the program ClustalX2^[@R40]^ and illustrated using the ESPript server^[@R41]^.
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![Crystal structure of SUVH9\
a. Ribbon diagram of the SUVH9 crystal structure containing a two-helix bundle, SRA domain, pre-SET domain, and SET domain colored in pink, green, orange, and blue, respectively. The Zn~3~Cys~9~ cluster is highlighted in a ball-and-stick representation and disordered regions are shown with dashed lines.\
b. A superposition of SUVH9 SRA domain (in green) and SUVH5 SRA domain (in silver) shows that both proteins adopt a similar fold.\
c. Top panel: the crystal structure of human GLP in complex with bound SAH (PDB code: 2IGQ) in a silver ribbon representation. Bottom panel: the SAH binding site in an electrostatic surface representation. The cofactor SAH is shown in a space-filling representation.\
d. Top panel: the crystal structure of human GLP in complex with SAH and H3K9me2 peptide (PDB code: 2RFI) in silver ribbon representation. Bottom panel: the peptide binding site in an electrostatic surface representation. The post-SET domain and the acidic loop of the SET domain involved in peptide substrate binding are highlighted in cyan and dark blue, respectively. The bound peptide is shown in a space-filling representation in both panels.\
e. Top panel: the crystal structure of SUVH9 in the free state in a color-coded ribbon representation. Bottom panel: an expanded view of the putative SAH binding site in an electrostatic surface representation.\
f. Top panel: the crystal structure of SUVH9 in the free state in a color-coded ribbon representation. Bottom panel: an expanded view of the putative peptide-binding site in an electrostatic surface representation. The long insertion loop of the SET domain is highlighted in magenta.](nihms-545790-f0001){#F1}

![SUVH2 and SUVH9 are required for Pol V dependent siRNA production, chromatin binding, and transcription\
a. Boxplot (whiskers extend to ±1.5 interquartile range (IQR)) of RPKM values for 24-nt siRNAs at previously defined siRNA clusters dependent on Pol IV (NRPD1), but not Pol V (NRPE1). 24-nt counts allow for up to 100 identical reads to be counted at any given position. \* indicates a significant decrease (P\<2.2e-16, Mann-Whitney U test).\
b. Similar to plot in (a) for clusters defined as dependent on Pol IV and Pol V.\
c. Quantitative reverse transcription PCR (RT-qPCR) of IGN22 and P6 relative to ACTIN7 and normalized to Columbia-0 (WT). Mean +/− standard deviation (SD) of two biological replicas.\
d. Quantitative PCR (qPCR) of IGN22 and IGN5 from Flag ChIP shown as enrichment of IP/input relative to ACTIN7 in NRPE1-Flag/WT and NRPE1-Flag/*suvh2 suvh9* lines. Mean +/− SD of two biological replicas.\
e. Heat map of NRPE1 enrichment at defined NRPE1 sites determined by Flag ChIP-Seq in either NRPE1-Flag/WT or NRPE1-Flag/*suvh2 suvh9*, with Flag ChIP in WT as negative control.\
f. Box plot of NRPE1 enrichment at sites shown in Fig. 2e for NRPE1-Flag/WT and NRPE1-Flag/*suvh2 suvh9.*](nihms-545790-f0002){#F2}

![Pol V binding is dependent on DNA methylation\
a. Metaplot of percent CHH methylation at all defined NRPE1 binding sites as determined by BS-seq in wild type (WT), *nrpe1*, and *suvh2 suvh9*.\
b. Box plots showing DNA methylation in each cytosine context at defined NRPE1 binding sites in WT and *met1*.\
c. Pol V occupancy in *met1* is reduced at NRPE1 sites.\
d. Metaplot of DNA methylation at sites defined as hyper-methylated in *met1*.\
e. Pol V occupancy in *met1* is increased at defined hyper-methylated sites.](nihms-545790-f0003){#F3}

![Tethered SUVH2 recruits Pol V through DRD1, resulting in DNA methylation and a late-flowering phenotype\
a. Plants grown side-by-side to illustrate early flowering of ZF-SUVH2 in *fwa-4* (T2 plants) compared to *fwa-4.*\
b. Flowering time of Columbia-0 (WT), ZF-SUVH2 in *fwa-4*, ZF-KYP in *fwa-4*, HA-SUVH2 in *fwa-4*, and *fwa-4*. Flowering time was determined by counting all rosette and cauline leaves up until the terminal flower. The average leaf number and standard deviation of between 20-30 plants was determined. Mean +/− SD.\
c. Percent methylation at each cytosine in the *FWA* repeat region as determined by BS-seq in T2 and T3 ZF-SUVH2/*fwa-4* plants compared to T2 ZF-KYP/*fwa-4* (unmethylated) and WT (standard methylation pattern). ZF binding sites are shown in green and the *FWA* gene in blue.\
d. NRPE1 ChIP in WT (positive control), *nrpe1* mutant (negative control), *fwa-4* epiallele, and ZF-SUVH2/*fwa-4*. qPCR results of two well-characterized NRPE1 binding sites (IGN5 and IGN22) and two regions in FWA (FWAp: promoter; FWAt: transcript) are shown as enrichment of IP/input relative to negative control. Mean +/− SD of two biological replicas.\
e. Coimmunoprecipitation of HA-SUVH2 in Arabidopsis using Flag-DRD1. Left panels are inputs from the two parental strains (expressing either HA-SUVH2 (HA-2) or Flag-DRD1 (Flag-D)) and an F2 line expressing both HA-SUVH2 and Flag-DRD1 (HA-2xFlag-d). The right panels show elution from Flag-magnetic beads. Top panels are HA western blots, bottom panels are Flag western blots.](nihms-545790-f0004){#F4}

![Interdomain interactions of SUVH9\
a. Color-coded schematic representation of full length SUVH9 and the N-terminally truncated construct used for crystallization.\
b. The hydrophobic interactions and charged interactions within the two-helix bundle shown in two alternate views rotated by 180 degree. Residues involved in inter-helix hydrophobic interactions are highlighted in yellow.\
c. The N-terminal part of the first α-helix forms charged and hydrogen bonding interactions with the SRA domain and the SET domain. The interacting residues are shown in stick representation and the hydrogen-bonding interactions are shown with dashed red lines.\
d. The C-terminal part of the first α-helix exhibits extensive hydrophobic interactions with the SRA domain and the pre-SET/SET domains. The tip of a long loop from the SET domain covers over the first helix and forms hydrophobic interactions with it.\
e. The second α-helix forms some interactions with the SRA domain.\
f. The SRA domain forms a hydrophobic core that interacts with the pre-SET/SET domains.\
g. A long insertion loop of SUVH9 SET domain (highlighted in magenta) is enriched with hydrophobic residues and forms extensive hydrophobic interactions with the two-helix bundle, the pre-SET and SET domains.](nihms-545790-f0005){#F5}

![SUVH9 SRA and pre-SET/SET domains\
a. A model positioning the mCHH DNA to the active site of SUVH9 SRA domain following superposition of the structures of the SUVH5 SRA-mCHH complex \[PDB code: 3Q0F) and SUVH9 in the free state. SUVH9 domains are depicted with the same color-coding as in [Figure 1a](#F1){ref-type="fig"} and the modeled DNA is colored in yellow. The DNA fits well into the SRA domain without significant steric clashes. Some surrounding residues on the second α-helix of the two-helix bundle, which can potentially be involved in the binding to the DNA, are highlighted in a stick representation.\
b. A stereo view of the superposition of the structure of SUVH9 in the free state and the structure of human GLP catalytic fragment complexed with SAH (PDB code: 2IGQ). The GLP pre-SET and SET domains are colored in silver and its post-SET domain is colored in cyan. The zinc-binding motif of GLP post-SET domain and SET domain, the bound SAH molecule, and the corresponding Thr597 of SUVH9 are highlighted in a stick representation.](nihms-545790-f0006){#F6}

![Structure-based sequence alignment of SUVH family proteins from Arabidopsis\
The secondary structural elements of SUVH9 are labeled on the top of the sequence alignment. The domain boundaries are marked on the top and depicted with color-coding as in [Figure 1a](#F1){ref-type="fig"}. Conserved residues involved in the interaction with flipped 5mC base and the DNA backbone available from the published SUVH5-DNA complex structures are highlighted with cyan circles and blue hexagons, respectively. The insertions in the SET domains are highlighted with a purple box. The zinc-coordinating Cys residues are highlighted with black stars in the SET domain and grey stars in the post-SET domain. Two-tyrosine residues that are conserved and normally important for enzymatic activity are highlighted with red dots.](nihms-545790-f0007){#F7}

![SUVH2 and SUVH9 act redundantly genome-wide\
a. Metaplots of CHH methylation over DMRs identified in the various SUVH mutants.\
b. Metaplots of CHH methylation over Pol V binding sites.\
c. Venn diagram detailing the overlaps between CHH hypo-methylated regions in SUVH mutants.](nihms-545790-f0008){#F8}

![Pol V occupancy in WT versus *met1*\
Chromosome 1 showing Pol V ChIP in WT versus *met1* as mapped over TAIR10 (green genes, red TE).](nihms-545790-f0009){#F9}

![Screen shot of Pol V binding in WT versus *met1*\
An example of reduced Pol V binding in *met1* at sites that become hypomethylated.](nihms-545790-f0010){#F10}

![Screen shot of Pol V binding in WT versus *met1.*\
Reduction in Pol V binding in a *met1* hypomethylated site.](nihms-545790-f0011){#F11}

![Screen shot of Pol V binding at a hyper-CHH methylated site in WT versus *met1*\
An example of Pol V being redistributed to regions that gain methylation in *met1*.](nihms-545790-f0012){#F12}

![Pol V binding at hyper-CHH methylated site that is also transcribed\
Strong Pol V binding was detected at regions in the genome that not only retained high levels of non-CG methylation, but also were transcriptionally activated in *met1*.](nihms-545790-f0013){#F13}

![ZF-SUVH2 construct stably recruits Pol V to *FWA* through a direct interaction with DRD1\
a. Top: Diagram of *SUVH2* with Zn Finger (ZF) inserted immediately before the HA tag. Bottom: Schematic of *FWA* gene showing the two small and two large repeats (blue arrows), the regions amplified by PCR (promoter and transcript: green lines), the start and direction of transcription (red arrow), and the sites bound by the ZF (indicated by two orange arrows).\
b. Flag-ChIP in WT versus ZF-KYP (flag-tagged) showing enrichment at *FWA* in both the promoter and transcript region (see above).\
c. Percent methylation at each C in the *FWA* repeat region from three individual T1 plants. Percent methylation was determined from 20-25 clones of bisulfite-treated DNA.\
d. BS-Seq of *FWA* from a Basta-resistant line containing the ZF-SUVH2 transgene and two Basta-sensitivie siblings which had lost the ZF-SUVH2 transgene.\
e. Pull-down of DRD1-Flag with ZF-SUVH2. Input: DRD1-Flag extract from Arabidopsis; Beads-mock: elution from DRD1-Flag pull-down using HA-magnetic beads pre-bound with *Nicotiana benthamiana* extract; Beads-ZF-SUVH2: elution from DRD1-Flag pull-down using HA-magnetic beads pre-bound with *Nicotiana benthamiana* ZF-SUVH2 extract. Top panel: Flag blot; bottom panel: HA blot.](nihms-545790-f0014){#F14}
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